Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.5.3 to v3.5.4 in the page footer, indicating a new build. This metadata change does not modify study content, results, or eligibility information.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a minor update to the study record. This change does not affect the study details or how users interact with the page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe site revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated to v3.5.0 and the previous v3.4.3 label was removed.SummaryDifference0.1%

- Check65 days agoChange DetectedUpdated page revision label to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision: v3.4.2 was added; notices about government funding and the prior revision (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.